empty

Sanofi

8 results found for: Sanofi

Biological medicines and biosimilars

This module explores biological and biosimilar medicines, and will increase your understanding of the guidelines surrounding the brand prescribing of these drugs and your role in their supply

Experimental RSV drug ‘promising’ says MHRA

The MHRA has granted a ‘promising innovative medicine’ designation to experimental RSV drug nirsevimab. 

MHRA recalls batches of Epilim 500mg gastro-resistant tablets

The MHRA has recalled batches of Epilim 500mg gastro-resistant tablets.

UK government agrees fourth Covid vaccine deal

The two companies will supply the UK with 60 million doses of their protein adjuvant Covid-19 vaccine.

Supporting daily digestive health

Learn about the crucial role of gut bacteria and how a healthy microbiome can support daily digestive health

Understanding abdominal pain, cramps and IBS

This short video explains the symptoms of irritable bowel syndrome (IBS) and how it differs from abdominal cramps to help you recommend a suitable product for your customer’s needs.

Gabitril shortages to last until end of October

Teva has warned that shortages of the epilepsy drug will last a month long longer than previously expected.

Pharmacy minister grilled on epilepsy drug shortages

The DHSC will reiterate its “great concern” to the suppliers of an epilepsy drug that has been affected by shortages, Seema Kennedy told the Commons



This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.